SGP (SpyGlass Pharma) OCF Margin %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGP SpyGlass Pharma Inc SGP
12 GF Score
Price $25.07
View Full Analysis

What is SpyGlass Pharma OCF Margin %?

SpyGlass Pharma SGP -0.59% 12 OCF Margin % is 0.00% as of Jun. 2026. GuruFocus rates SGP with a GF Score™ of 12/100. Among 953 Biotechnology companies, SpyGlass Pharma ranks worse than 104931.69% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. SpyGlass Pharma's Cash Flow from Operations for the three months ended in Jun. 2026 was $-14.84 Mil. SpyGlass Pharma's Revenue for the three months ended in Jun. 2026 was $0.00 Mil. Therefore, SpyGlass Pharma's OCF Margin % for the quarter that ended in Jun. 2026 was 0.00%.

As of today, SpyGlass Pharma's current OCF Yield % is -5.55%.

The historical rank and industry rank for SpyGlass Pharma's OCF Margin % or its related term are showing as below:


SGP's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.92
* Ranked among companies with meaningful OCF Margin % only.

SpyGlass Pharma OCF Margin % Related Terms

SpyGlass Pharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for SpyGlass Pharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpyGlass Pharma OCF Margin % Chart

SpyGlass Pharma Annual Data
Trend Dec23 Dec24 Dec25
OCF Margin %
0.00 0.00 0.00

SpyGlass Pharma Quarterly Data
Dec23 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
SGP
12GF Score
SpyGlass Pharma Inc SGP
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SpyGlass Pharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

SpyGlass Pharma's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-32.701/0
= %

SpyGlass Pharma's OCF Margin for the quarter that ended in Jun. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-14.839/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
SpyGlass Pharma (SGP) has a OCF Margin % of 0.00% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SpyGlass Pharma and its competitors. According to the industry distribution chart, SpyGlass Pharma ranks #999999 out of 953 companies in the Biotechnology industry.
Is SpyGlass Pharma's OCF Margin % too high?
SpyGlass Pharma's current OCF Margin % is 0.00%. Based on the distribution chart, SpyGlass Pharma ranks #999999 out of 953 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, SpyGlass Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does SpyGlass Pharma's OCF Margin % compare to RIGL and NGNE?
According to the Biotechnology industry distribution chart, SpyGlass Pharma ranks #999999 out of 953 companies for OCF Margin %. This places SpyGlass Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SpyGlass Pharma and its competitors. SpyGlass Pharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpyGlass Pharma stock overvalued right now?
SpyGlass Pharma (SGP) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. SpyGlass Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For SpyGlass Pharma (SGP), the current OCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpyGlass Pharma Business Description

Address 27061 Aliso Creek Road, Suite 100, Aliso Viejo, CA, USA, 92656
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
12GF Score

Get the complete analysis for SGP

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.07
Price